YiChang HEC ChangJiang Pharmaceutical 대차 대조표 상태
재무 상태 기준 확인 6/6
YiChang HEC ChangJiang Pharmaceutical 의 총 주주 지분은 CN¥8.7B 이고 총 부채는 CN¥2.1B, 이는 부채 대 자기자본 비율을 23.9% 로 가져옵니다. 총자산과 총부채는 각각 CN¥12.5B 및 CN¥3.8B 입니다. YiChang HEC ChangJiang Pharmaceutical 의 EBIT는 CN¥2.1B 이며 이자보상배율은 30.4 입니다. CN¥1.5B 의 현금 및 단기 투자금을 보유하고 있습니다.
주요 정보
23.9%
부채 비율
CN¥2.07b
부채
| 이자 보상 비율 | 30.4x |
| 현금 | CN¥1.52b |
| 주식 | CN¥8.67b |
| 총 부채 | CN¥3.83b |
| 총 자산 | CN¥12.49b |
최근 재무 상태 업데이트
YiChang HEC ChangJiang Pharmaceutical (HKG:1558) Could Easily Take On More Debt
Sep 25
Does YiChang HEC ChangJiang Pharmaceutical (HKG:1558) Have A Healthy Balance Sheet?
Nov 25Is YiChang HEC ChangJiang Pharmaceutical (HKG:1558) A Risky Investment?
Mar 23Here's Why YiChang HEC ChangJiang Pharmaceutical (HKG:1558) Has A Meaningful Debt Burden
Apr 13Recent updates
YiChang HEC ChangJiang Pharmaceutical (HKG:1558) Strong Profits May Be Masking Some Underlying Issues
Oct 07Should You Be Adding YiChang HEC ChangJiang Pharmaceutical (HKG:1558) To Your Watchlist Today?
Sep 19YiChang HEC ChangJiang Pharmaceutical Co., Ltd.'s (HKG:1558) Popularity With Investors Under Threat As Stock Sinks 26%
May 29Do YiChang HEC ChangJiang Pharmaceutical's (HKG:1558) Earnings Warrant Your Attention?
Apr 23YiChang HEC ChangJiang Pharmaceutical Co., Ltd.'s (HKG:1558) P/S Is Still On The Mark Following 33% Share Price Bounce
Mar 01Investors Appear Satisfied With YiChang HEC ChangJiang Pharmaceutical Co., Ltd.'s (HKG:1558) Prospects As Shares Rocket 33%
Mar 01YiChang HEC ChangJiang Pharmaceutical Co., Ltd.'s (HKG:1558) Business Is Trailing The Industry But Its Shares Aren't
Jan 03YiChang HEC ChangJiang Pharmaceutical (HKG:1558) Could Easily Take On More Debt
Sep 25Does YiChang HEC ChangJiang Pharmaceutical (HKG:1558) Have A Healthy Balance Sheet?
Nov 25Is YiChang HEC ChangJiang Pharmaceutical (HKG:1558) A Risky Investment?
Mar 23Does This Valuation Of YiChang HEC ChangJiang Pharmaceutical Co., Ltd. (HKG:1558) Imply Investors Are Overpaying?
Oct 29Here's Why YiChang HEC ChangJiang Pharmaceutical (HKG:1558) Has A Meaningful Debt Burden
Apr 13YiChang HEC ChangJiang Pharmaceutical Co., Ltd. (HKG:1558) Analysts Just Cut Their EPS Forecasts Substantially
Mar 23YiChang HEC ChangJiang Pharmaceutical's(HKG:1558) Share Price Is Down 55% Over The Past Three Years.
Mar 13YiChang HEC ChangJiang Pharmaceutical (HKG:1558) Is Growing Earnings But Are They A Good Guide?
Feb 20
Do Institutions Own YiChang HEC ChangJiang Pharmaceutical Co., Ltd. (HKG:1558) Shares?
Feb 02YiChang HEC ChangJiang Pharmaceutical Co., Ltd.'s (HKG:1558) Stock Has Been Sliding But Fundamentals Look Strong: Is The Market Wrong?
Dec 26Key Things To Watch Out For If You Are After YiChang HEC ChangJiang Pharmaceutical Co., Ltd.'s (HKG:1558) 5.1% Dividend
Dec 13What Type Of Returns Would YiChang HEC ChangJiang Pharmaceutical's(HKG:1558) Shareholders Have Earned If They Purchased Their SharesYear Ago?
Nov 30재무 상태 분석
단기부채: 1558 의 단기 자산 ( CN¥5.5B )이 단기 부채( CN¥2.5B ).
장기 부채: 1558 의 단기 자산( CN¥5.5B )이 장기 부채( CN¥1.3B ).
부채 대 자본 내역 및 분석
부채 수준: 1558 의 순부채 대 자기자본 비율( 6.3% )은 satisfactory로 간주됩니다.
부채 감소: 1558 의 부채 대 자기자본 비율은 지난 5년간 74.6% 에서 23.9% 로 감소했습니다.
부채 범위: 1558 의 부채는 영업 현금 흐름 ( 21.9% )에 의해 잘 충당되었습니다.
이자 보장: 1558 의 부채에 대한 이자 지급은 EBIT( 30.4 x 적용 범위)로 잘 충당됩니다.